Loading insider details...
Beta
Latest Form 4 (Feb 13, 2026): Grant/Award of 1,575 ENTA shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Feb 13, 2026 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/Award | 1,575 | n/a |
| Dec 5, 2025 | ENANTA PHARMACEUTICALS INC (ENTA) | Sale | 2,106 | $30.0K |
| Dec 3, 2025 | ENANTA PHARMACEUTICALS INC (ENTA) | Tax Withholding | 753 | $10.6K |
| Nov 26, 2025 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/Award | 100,000 | n/a |
| Feb 14, 2025 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/Award | 7,500 | n/a |
| Dec 10, 2024 | ENANTA PHARMACEUTICALS INC (ENTA) | Sale | 2,283 | $18.4K |
| Dec 3, 2024 | ENANTA PHARMACEUTICALS INC (ENTA) | Tax Withholding | 753 | $6.5K |
| Nov 27, 2024 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/Award | 81,000 | n/a |
| Jun 18, 2024 | ENANTA PHARMACEUTICALS INC (ENTA) | Sale | 7,266 | $89.6K |
| Feb 15, 2024 | ENANTA PHARMACEUTICALS INC (ENTA) | Grant/Award | 3,320 | n/a |